Sachdev Thomas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sachdev Thomas has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Adedayo A. Onitilo
Cancer Care and Research Center, Sanford-Marshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI 54449, USA
101 shared publications - Alan M. Miller
Translational Drug Development, Scottsdale, Arizona
101 shared publications - Amanda Falzetta
Strata Oncology, Ann Arbor, Michigan
101 shared publications - Anna C. Dusenbery
Strata Oncology, Ann Arbor, Michigan
101 shared publications - Benjamin J. Bulen
Strata Oncology, Ann Arbor, Michigan
101 shared publications - Benjamin M. Parsons
Gundersen Health System, La Crosse, Wisconsin, United States
101 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Treatment and Outcomes among Patients with mCRPC with an AR Gene Alteration: Analysis from the Kaiser Permanente Northern California Healthcare System.
From the 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy
- 10 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Open AccessTreatment and Outcomes among Patients with mCRPC with an AR Gene Alteration: Analysis from the Kaiser Permanente Northern California Healthcare System.
From the 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy
- Open Access
- 9 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Feasibility of a Novel Recurrence Algorithm to Improve NGS Testing in a Cohort of ER+/HER2- Metastatic Breast Cancer Patients in Kaiser Permanente Northern California
From the 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy
- 9 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Open AccessFeasibility of a Novel Recurrence Algorithm to Improve NGS Testing in a Cohort of ER+/HER2- Metastatic Breast Cancer Patients in Kaiser Permanente Northern California
From the 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Table S1 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients with wt and mut TP53.
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients with wt and mut TP53.
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Table S3 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients wt and mut Rb1.
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients wt and mut Rb1.
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Table S5 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients with wt and mut ATRX.
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients with wt and mut ATRX.
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Table S4 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients with wt and mut PTEN.
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients with wt and mut PTEN.
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Figure S1 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
OS comparison between Stanford and KPNC cohort
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
OS comparison between Stanford and KPNC cohort
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Figure S1 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
OS comparison between Stanford and KPNC cohort
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
OS comparison between Stanford and KPNC cohort
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Table S3 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients wt and mut Rb1.
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients wt and mut Rb1.
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Table S5 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients with wt and mut ATRX.
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Demographics of patients with wt and mut ATRX.